New research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, found that JAK inhibitors (JAKi) and tocilizumab elicited better response rates in VEXAS syndrome ...
David Adams spent half a decade fighting an illness he couldn’t name. He was in and out of the hospital several times per year. His inflamed joints made his hands feel like they had been squeezed into ...
Researchers at Memorial Sloan Kettering Cancer Center (MSK) have developed some of the first robust laboratory models of a confounding adult-onset inflammatory disease called VEXAS syndrome — shedding ...
Shared inflammatory signatures in vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome, myelodysplasia cutis (MDS-cutis), and Sweet syndrome (SS) suggest interferon pathways as ...
New research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, found that JAK inhibitors (JAKi) and tocilizumab elicited better response rates in VEXAS syndrome ...
Share on Pinterest Researchers say VEXAS syndrome is often diagnosed in people with other autoimmune diseases. FG Trade/Getty Images Scientists are expressing concerns over a newly identified ...
About 13,200 men and another 2,300 women in the United States over age 50 are estimated to have VEXAS syndrome, according to a new study. Long considered a mystery illness until its genetic basis was ...
First described in 2020 by researchers from the US National Institutes of Health (NIH), VEXAS syndrome is a systemic autoinflammatory disease of undefined origin. Its name is an acronym: Vacuoles, E1 ...
Please provide your email address to receive an email when new articles are posted on . VEXAS syndrome often has skin manifestations, but these often mimic symptoms of Sweet syndrome or vasculitis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results